Clinical Trials Browser

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

97 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT01345136 2024-02-13

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Phase 2 Terminated

4 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT04801953 2023-10-19

Nimodipine in Vestibular Schwanommas

Phase 2 Unknown

30 enrolled

CNS

Neuroma, Acoustic

NCT04351373 2023-08-01

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Phase 2 Completed

12 enrolled 11 charts

CNS

Neuroma, Acoustic

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

13 enrolled 7 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01125046 2021-01-22

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Phase 2 Completed

50 enrolled 13 charts

CNS

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

NCT01207687 2018-08-27

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase 2 Completed

14 enrolled 28 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT03393689 2018-01-10

RGD PET/MRI in Sporadic Vestibular Schwannoma

Phase 2 Unknown

40 enrolled

CNS

Neuroma, Acoustic

NCT01490476 2017-05-23

AFINF2

Phase 2 Completed

10 enrolled

CNS

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2

NCT02104323 2017-02-09

Endostatin

Phase 2 Completed

20 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase 2 Completed

21 enrolled 8 charts

CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

Clinical Trials

INTUITT-NF2

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Study of Aspirin in Patients With Vestibular Schwannoma

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

SEL-TH-1601

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Nimodipine in Vestibular Schwanommas

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

RGD PET/MRI in Sporadic Vestibular Schwannoma

AFINF2

Endostatin

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2